The analysis showed that hypertrophic cardiomyopathy, dilated cardiomyopathy, vascular smooth muscle contraction, transforming growth factor (TGF)-β signaling pathway, and other cardiomyopathy-related biological signaling pathways were enriched in the myocardial disease group (Figures 4A, B). This evidence concerns the gene TGFB1 and myocardial disorder.